The new representation centre is expected to intensify Gerresheimer’s business in pharmaceutical primary packaging and drug-delivery systems.
Gerresheimer said that the regional representation is expected to contribute to intensification not only of sales operations but also customer advice and technical service on the spot. In general, the Russian pharma industry has a strong interest in developing its quality and technologies together with competent partners.
Axel Herberg, CEO of Gerresheimer, said: “This is a strategically important step to further develop the fast-growing pharma and healthcare markets of Russia and neighboring regions.”